Immunologic effects of estramustine phosphate.
暂无分享,去创建一个
[1] J. Müntzing,et al. Pilot study on the growth inhibition by estramustine phosphate (Estracyt) of rat mammary tumours sensitive and insensitive of oestrogen. , 2009, Acta pharmacologica et toxicologica.
[2] T. Kalland,et al. Effects of diethylstilbestrol on human natural killer cells in vitro. , 1984, Immunopharmacology.
[3] T. Kalland,et al. Effects of diethylstilbestrol and estramustine phosphate (Estracyt) on lymphoid cell populations and mitogen responsiveness in male mice. , 1982, The Journal of urology.
[4] P. Gunnarsson,et al. Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145). , 1982, The Journal of urology.
[5] T. Kalland,et al. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer. , 1981, Investigative urology.
[6] R. Luebke,et al. The effect of adult exposure to diethylstilbestrol in the mouse: alterations in immunological functions. , 1980, Journal of the Reticuloendothelial Society.
[7] Kendall A. Smith,et al. T‐Cell Growth Factor , 1980, Immunological reviews.
[8] F. Richard,et al. Estramustine phosphate in the treatment of advanced prostatic cancer. , 1980, British journal of urology.
[9] T. Kalland,et al. Effect of estrogen and corticosterone on the lymphoid system in neonatal mice. , 1978, Experimental and molecular pathology.
[10] D. L. Greenman,et al. Strain differences in the response of the mouse to diethylstilbestrol. , 1977, Journal of toxicology and environmental health.
[11] O. Haller,et al. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. , 1977, Journal of immunology.
[12] Høisaeter Pa. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts. , 1976 .
[13] J. Kenny,et al. Effect of estradiol on immune competence: in vivo and in vitro studies , 1976, Infection and immunity.
[14] S. Haukaas,et al. Suppression of antibody response of male mice exposed to diethylstilbestrol or estramustine phosphate (estracytR) , 1983, The Prostate.
[15] T. Kalland,et al. Effect of diethylstilbestrol and estramustine phosphate (estracyt®) on delayed hypersensitivity response to oxazolone in male mice , 1982, The Prostate.
[16] T. Kalland,et al. In vitro and in vivo effects of diethylstilbestrol and estramustine phosphate (estracyt®) on the mitogen responsiveness of human peripheral blood lymphocytes , 1982, The Prostate.
[17] Høisaeter Pa. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate. , 1977 .
[18] B. Högberg,et al. Treatment of advanced prostatic carcinoma with Estracyt. A preliminary report. , 1971, Scandinavian journal of urology and nephrology.
[19] B. Vernon‐roberts. The effects of steroid hormones on macrophage activity. , 1969, International review of cytology.